Annelies de Weerd

Annelies de Weerd is a researcher at Erasmus MC in the Department of Internal Medicine, focusing on kidney transplantation and transplant immunology. Her work contributes significantly to understanding graft survival, donor-specific HLA antibodies, and desensitization protocols.

Her research interests include kidney transplantation, antibody-mediated rejection, graft survival, desensitization therapies (such as imlifidase), living donor transplantation, and transplant immunology. She investigates factors influencing transplant outcomes, including donor age and immune sensitization.

The recent publications highlight a strong focus on clinical outcomes, systematic reviews, and international consensus development in kidney transplantation. Key themes include risk prediction models, HLA incompatibility management, and post-transplant metabolic complications such as diabetes.

Dr. de Weerd collaborates extensively with European and international experts in nephrology and transplantation, contributing to guidelines and large-scale studies through working groups like ERA DESCARTES.